Cargando…
Antiviral immunity is impaired in COPD patients with frequent exacerbations
Patients with frequent exacerbations represent a chronic obstructive pulmonary disease (COPD) subgroup requiring better treatment options. The aim of this study was to determine the innate immune mechanisms that underlie susceptibility to frequent exacerbations in COPD. We measured sputum expression...
Autores principales: | Singanayagam, Aran, Loo, Su-Ling, Calderazzo, Maria, Finney, Lydia J., Trujillo Torralbo, Maria-Belen, Bakhsoliani, Eteri, Girkin, Jason, Veerati, Punnam, Pathinayake, Prabuddha S., Nichol, Kristy S., Reid, Andrew, Footitt, Joseph, Wark, Peter A. B., Grainge, Christopher L., Johnston, Sebastian L., Bartlett, Nathan W., Mallia, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962603/ https://www.ncbi.nlm.nih.gov/pubmed/31513433 http://dx.doi.org/10.1152/ajplung.00253.2019 |
Ejemplares similares
-
Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
por: Calderazzo, Maria Adelaide, et al.
Publicado: (2019) -
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2018) -
Comparison of commercially available differentiation media on cell morphology, function, and anti-viral responses in conditionally reprogrammed human bronchial epithelial cells
por: Awatade, Nikhil T., et al.
Publicado: (2023) -
Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection
por: Veerati, Punnam Chander, et al.
Publicado: (2023) -
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)